Veeva Systems delivered a strong finish to fiscal 2026, underscoring durable profitability and cash generation in a high-growth life sciences cloud ecosystem. Q4 2026 revenue of $835.95 million exceeded guidance and brought full-year revenue to $3.196 billion, up 15.96% year over year. The company posted a robust gross margin of 74.46% and non-GAAP operating income of $366 million in the quarter, contributing to full-year non-GAAP operating income of $1.434 billion. Management highlighted the resilience of Vault CRM and the accelerating adoption of Crossix, while signaling that AI-driven automation remains a core but not sole driver of demand. Strategic emphasis remains on platform consolidation (CRM, Vault, OpenData/Network), scalable RTSM, and a growing study-by-study services cadence via CROs. The guidance framework emphasizes annual normalized billings with a 13% revenue growth target for FY2027, while maintaining discretion around quarterly guidance. The balance sheet remains exceptionally strong with sizable cash and investments, a net cash position, and modest leverage, underpinning ongoing investments in product development and go-to-market expansion.